Debt-to-equity of Black Diamond Therapeutics, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Black Diamond Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Black Diamond Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 29%, a 22% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Black Diamond Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 29% -8% -22% 30 Sep 2025
Q2 2025 33% -1% -3.3% 30 Jun 2025
Q1 2025 35% 0% -0.36% 31 Mar 2025
Q4 2024 40% +4% +11% 31 Dec 2024
Q3 2024 37% +1% +4.1% 30 Sep 2024
Q2 2024 34% -4% -11% 30 Jun 2024
Q1 2024 36% +1% +3.6% 31 Mar 2024
Q4 2023 36% +4% +14% 31 Dec 2023
Q3 2023 36% +6% +21% 30 Sep 2023
Q2 2023 38% +11% +40% 30 Jun 2023
Q1 2023 34% +12% +51% 31 Mar 2023
Q4 2022 32% +13% +69% 31 Dec 2022
Q3 2022 29% +16% +113% 30 Sep 2022
Q2 2022 27% +18% +186% 30 Jun 2022
Q1 2022 23% +16% +259% 31 Mar 2022
Q4 2021 19% +15% +353% 31 Dec 2021
Q3 2021 14% +10% +258% 30 Sep 2021
Q2 2021 9% 30 Jun 2021
Q1 2021 6% 31 Mar 2021
Q4 2020 4% 31 Dec 2020
Q3 2020 4% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.